Erschienen in:
01.03.2018 | Case Report
Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinoma
verfasst von:
Ryosuke Kochi, Satoshi Yajima, Tatsuki Nanami, Takashi Suzuki, Yoko Oshima, Natsuki Tokura, Jun Takatsuka, Kimihiko Funahashi, Naobumi Tochigi, Hideaki Shimada
Erschienen in:
Clinical Journal of Gastroenterology
|
Ausgabe 4/2018
Einloggen, um Zugang zu erhalten
Abstract
Serum p53 antibody (s-p53-Ab) titers were postoperatively monitored for over 5 years in a 67-year-old man with locally advanced esophageal squamous cell carcinoma. The tumor stage was classified as clinical stage II (cT3N0M0). Serum SCC antigen (s-SCC-Ag; 6.2 ng/mL) and s-p53-Ab (3.83 U/mL) were noted to be positive before surgery. Radical esophagectomy with three-field lymph node dissection was performed without neoadjuvant therapy. Pathological findings of the surgically resected specimens revealed a stage II tumor (pT3N0M0). Postoperatively, the patients did not receive any adjuvant therapy. Although the s-SCC-Ag was found to be negative at 2 months postoperatively, s-SCC-Ag was found to be six times positive despite no signs of recurrence. The s-p53-Ab titers constantly decreased to less than the cutoff value at 6 months postoperatively and continuously decreased over 5 years postoperatively. Finally, s-p53-Ab titers became less than the detection limit value at 60 months postoperatively. No recurrence was observed throughout the postoperative course. This case report is the first to describe the five-year monitoring of postoperative changes in s-p53-Ab titers in a patient with locally advanced esophageal squamous cell carcinoma without recurrence. s-p53-Ab titers seemed to be more useful than s-SCC-Ag for disease monitoring in this case.